Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prais

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2024
Treatment effects of elexacaftor/tezacaftor/ivacaftor on people with cystic fibrosis heterozygous for 3849+10kbC->T and a class I variantMoshe Heching, Michal Shteinberg, Inbal Golan-Tripto, et al.
Respiratory Medicine|June 5, 2026
PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS AFTER FATHERHOOD WITH AND WITHOUT CFTR MODULATORSMalena Cohen-Cymberknoh, Shavit Malca Hadad, Michal Shteinberg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 12, 2023
Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort StudyVered Wiesel, Micha Aviram, Meir Mei-Zahav, et al.
Journal of Clinical Medicine|November 14, 2023
Pulmonary Evaluation in Children with Post-COVID-19 Condition Respiratory Symptoms: A Prospective Cohort StudyEinat Shmueli, Ophir Bar-On, Ben Amir, et al.
The Israel Medical Association Journal : IMAJ|July 13, 2006
Lung transplantation in patients with cystic fibrosis: the Israeli experienceDario Prais, Yael Raviv, David Shitrit, et al.
Respiration; International Review of Thoracic Diseases|May 28, 2026
Non-tuberculous mycobacteria in primary ciliary dyskinesia: a national multicenter cohort studyOphir Bar-On, Saharon Less Elazari, Haim Ben-Zvi, et al.
Pediatric Pulmonology|December 23, 2022
High flow nasal cannula therapy in the pediatric home settingShay Ehrlich, Inbal Golan Tripto, Moran Lavie, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2018
The Q359K/T360K mutation causes cystic fibrosis in Georgian JewsM Mei-Zahav, P Stafler, H Senderowitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1)M K Rutter, H R Prais, V Charlton-Menys, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 21, 2015
The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screeningPatrick Stafler, Meir Mei-Zahav, Michael Wilschanski, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2024
Treatment effects of elexacaftor/tezacaftor/ivacaftor on people with cystic fibrosis heterozygous for 3849+10kbC->T and a class I variantMoshe Heching, Michal Shteinberg, Inbal Golan-Tripto, et al.
Respiratory Medicine|June 5, 2026
PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS AFTER FATHERHOOD WITH AND WITHOUT CFTR MODULATORSMalena Cohen-Cymberknoh, Shavit Malca Hadad, Michal Shteinberg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 12, 2023
Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort StudyVered Wiesel, Micha Aviram, Meir Mei-Zahav, et al.
Journal of Clinical Medicine|November 14, 2023
Pulmonary Evaluation in Children with Post-COVID-19 Condition Respiratory Symptoms: A Prospective Cohort StudyEinat Shmueli, Ophir Bar-On, Ben Amir, et al.
The Israel Medical Association Journal : IMAJ|July 13, 2006
Lung transplantation in patients with cystic fibrosis: the Israeli experienceDario Prais, Yael Raviv, David Shitrit, et al.
Respiration; International Review of Thoracic Diseases|May 28, 2026
Non-tuberculous mycobacteria in primary ciliary dyskinesia: a national multicenter cohort studyOphir Bar-On, Saharon Less Elazari, Haim Ben-Zvi, et al.
Pediatric Pulmonology|December 23, 2022
High flow nasal cannula therapy in the pediatric home settingShay Ehrlich, Inbal Golan Tripto, Moran Lavie, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2018
The Q359K/T360K mutation causes cystic fibrosis in Georgian JewsM Mei-Zahav, P Stafler, H Senderowitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1)M K Rutter, H R Prais, V Charlton-Menys, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 21, 2015
The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screeningPatrick Stafler, Meir Mei-Zahav, Michael Wilschanski, et al.
Pageof 17